To Evaluate the Efficacy Treatment of Lower Extremity Pathologies Derived From Neurological Ischemia Disorders
Status: Active_not_recruiting
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Physician Clinical Trial Policy (CTP) to evaluate the efficacy treatment of lower extremity pathologies derived from neurological ischemia disorders using the combination of Monochromatic Infrared Photo Energy (MIRE) and Transcutaneous Electrical Nerve Stimulation (TENS) therapies.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 25
Maximum Age: 90
Healthy Volunteers: f
View:
• In the investigator's judgment, a high probability of 5 year survival and compliance with the study visit schedule.
⁃ Ability to comprehend and sign an informed consent document prior to study enrollment.
Time Frame
Start Date: 2012-03
Completion Date: 2026-03
Participants
Target number of participants: 1000
Treatments
Experimental: Anodyne
To evaluate the efficacy treatment of lower extremity pathologies from neurological ischemia disorders using the Monochromatic Infrared Photo Energy (MIRE)
Authors
Sponsors
Leads: American Association of Sensory Electrodiagnostic Medicine